Atlas Trials

The ED95 Dose of Sugammadex to Reverse Rocuronium-Induced Deep Neuromuscular Block Back to Shallow Neuromuscular Block

Clinical trial NCT05841316 · UNKNOWN

Trial details

NCT number
NCT05841316
Sponsor
Ankara University
Status
UNKNOWN
Study type
OBSERVATIONAL
Deep Neuromuscular BlockadeAnesthesia, General
Start date
2023-10-01
Primary completion
2023-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.